Genomic Valley Biotech Ltd. benchmarking: Perfomance to industry peers

Financial

	Genomic Valley	Omega Ag-Seeds	Camson Bio
Operational Metrics
Financials
5 yr Average ROE	3.03 %	1935.05 %	n/a
5yr average Equity Multiplier	1.32	-17.81	n/a
5yr Average Asset Turnover Ratio	0.18	0.0	n/a
5yr Avg Net Profit Margin	-41.34 %	0.0	n/a
Price to Book	2.29	0.0	n/a
P/E	0.0	11.77	n/a
5yr Avg Cash Conversion Cycle	594.64 Days	0.0	n/a
Inventory Days	24.59 Days	0.0	n/a
Days Receivable	1026.01 Days	0.0	n/a
Days Payable	914.42 Days	0.0	n/a
5yr Average Interest Coverage Ratio	618.83	-1278.52	n/a
5yr Avg ROCE	4.48 %	2300.56 %	n/a
5yr Avg Operating Profit Margin	-101.32 %	0.0	n/a
5 yr average Debt to Equity	0.07	-0.31	n/a
5yr CAGR Net Profit	n/a	n/a	n/a
5yr Average Return on Assets	3.12 %	-386.02 %	n/a
Shareholdings
Promoter Holding	46.06 %	0.7 %	n/a
Share Pledged by Promoters	0.0	0.0	n/a
Change in Promoter Holding (3 Yrs)	-21.79 %	-19.49 %	n/a
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	n/a